Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

NASDAQ:SNBR - Nasdaq - US83125X1037 - Common Stock - Currency: USD

6.72  -0.08 (-1.18%)

After market: 6.72 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SNBR. SNBR was compared to 122 industry peers in the Specialty Retail industry. SNBR has a bad profitability rating. Also its financial health evaluation is rather negative. SNBR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SNBR had negative earnings in the past year.
SNBR had a negative operating cash flow in the past year.
In multiple years SNBR reported negative net income over the last 5 years.
SNBR had a positive operating cash flow in 4 of the past 5 years.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

SNBR has a worse Return On Assets (-2.57%) than 63.93% of its industry peers.
SNBR has a Return On Invested Capital (4.30%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SNBR is significantly below the industry average of 12.95%.
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROIC 4.3%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

SNBR has a Operating Margin of 1.66%. This is comparable to the rest of the industry: SNBR outperforms 48.36% of its industry peers.
In the last couple of years the Operating Margin of SNBR has declined.
With an excellent Gross Margin value of 60.25%, SNBR belongs to the best of the industry, outperforming 88.52% of the companies in the same industry.
In the last couple of years the Gross Margin of SNBR has remained more or less at the same level.
Industry RankSector Rank
OM 1.66%
PM (TTM) N/A
GM 60.25%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SNBR is destroying value.
Compared to 1 year ago, SNBR has more shares outstanding
Compared to 5 years ago, SNBR has less shares outstanding
SNBR has a worse debt/assets ratio than last year.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SNBR has an Altman-Z score of 0.23. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
SNBR has a worse Altman-Z score (0.23) than 79.51% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.23
ROIC/WACC0.5
WACC8.6%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR's Current ratio of 0.19 is on the low side compared to the rest of the industry. SNBR is outperformed by 97.54% of its industry peers.
SNBR has a Quick Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR has a worse Quick ratio (0.08) than 97.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.08
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

SNBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.50%, which is quite impressive.
Looking at the last year, SNBR shows a very negative growth in Revenue. The Revenue has decreased by -12.35% in the last year.
SNBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%

3.2 Future

SNBR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.29% yearly.
The Revenue is expected to decrease by -0.23% on average over the next years.
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y36.29%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y-0.23%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
SNBR is valuated rather expensively with a Price/Forward Earnings ratio of 17.69.
SNBR's Price/Forward Earnings is on the same level as the industry average.
SNBR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 17.69
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNBR is valued cheaper than 99.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.67
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SNBR's earnings are expected to grow with 42.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.63%
EPS Next 3Y42.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SLEEP NUMBER CORP

NASDAQ:SNBR (6/27/2025, 8:00:02 PM)

After market: 6.72 0 (0%)

6.72

-0.08 (-1.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-16 2025-07-16/amc
Inst Owners78.28%
Inst Owner Change-15.54%
Ins Owners7.03%
Ins Owner Change32.46%
Market Cap152.28M
Analysts48.89
Price Target6.63 (-1.34%)
Short Float %17.63%
Short Ratio4.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-721.69%
Min EPS beat(2)-1452.29%
Max EPS beat(2)8.9%
EPS beat(4)3
Avg EPS beat(4)-345.92%
Min EPS beat(4)-1452.29%
Max EPS beat(4)41.39%
EPS beat(8)4
Avg EPS beat(8)-162.76%
EPS beat(12)7
Avg EPS beat(12)-69.04%
EPS beat(16)8
Avg EPS beat(16)-59.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.16%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-3.11%
Revenue beat(4)0
Avg Revenue beat(4)-4.52%
Min Revenue beat(4)-6.21%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.35%
Revenue beat(12)3
Avg Revenue beat(12)-2.76%
Revenue beat(16)4
Avg Revenue beat(16)-3.27%
PT rev (1m)-22%
PT rev (3m)-44.29%
EPS NQ rev (1m)2.27%
EPS NQ rev (3m)-19.44%
EPS NY rev (1m)19.9%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)-1.18%
Revenue NQ rev (3m)-5.33%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-12.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.69
P/S 0.09
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.67
EPS(TTM)-0.95
EYN/A
EPS(NY)0.38
Fwd EY5.65%
FCF(TTM)-1.24
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS70.83
BVpS-20.16
TBVpS-23.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.57%
ROE N/A
ROCE -39.51%
ROIC 4.3%
ROICexc 4.32%
ROICexgc 5%
OM 1.66%
PM (TTM) N/A
GM 60.25%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexcg growth 3Y-45.92%
ROICexcg growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score5
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.17
Cap/Depr 29.51%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.08
Altman-Z 0.23
F-Score5
WACC8.6%
ROIC/WACC0.5
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.15%
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y36.29%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-16.41%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y-0.23%
EBIT growth 1Y-7.48%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year253.84%
EBIT Next 3Y61.41%
EBIT Next 5Y51.25%
FCF growth 1Y20.84%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-130.66%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%